Close

About Our Group

The Mochida Group consists of Mochida Pharmaceutical Co., Ltd. and five consolidated subsidiaries, and is primarily engaged in the manufacturing, procurement, and sales of pharmaceuticals and healthcare-related products.

Mochida Pharmaceutical Plant Co., Ltd.


Main Business Manufacture of pharmaceuticals and healthcare products
Location 431, Nakadawara, Ohtawara City, Tochigi 324-0062, Japan(Head Office Plant)
Contact Information TEL +81-287-24-1111
FAX +81-287-24-1112
Paid-in Capital ¥500 million (wholly owned by Mochida Pharmaceutical)
Operations Commenced April 1, 2005
Representative Tadashi Morikawa, President

Mochida Healthcare Co., Ltd.

Main Business Sale of healthcare products
Location PAXXS Bldg., 2-12 Ichigayahonmuracho, Shinjuku-ku, Tokyo 162-8451, Japan
Contact Information TEL +81-3-5229-3940
FAX +81-3-5229-3973
Paid-in Capital ¥100 million (wholly owned by Mochida Pharmaceutical)
Operations Commenced April 1, 2004
Representative Shinji Akita, President

Mochida Pharmaceutical Sales Co., Ltd.

Main Business Sale of pharmaceuticals
Location PAXXS Bldg., 2-12 Ichigayahonmuracho, Shinjuku-ku, Tokyo 162-8451, Japan
Contact Information TEL +81-3-5229-3929
FAX +81-3-3269-9455
Paid-in Capital ¥10 million (wholly owned by Mochida Pharmaceutical)
Operations Commenced June 2, 2014
Representative Kazumasa Fukuchi, President

Technonet Co., Ltd.

Main Business Real estate brokerage and management of buildings and structures,
and administrative work related to accounting and purchasing on behalf of the company.
Location 7, Yotsuya 1-chome, Shinjuku-ku, Tokyo 160- 8515, Japan
Contact Information TEL +81-3-3353-7511
FAX +81-3-3353-7535
Paid-in Capital ¥82 million (wholly owned by Mochida Pharmaceutical)
Operations Commenced October 1, 2000
Representative Shigehiko Deguchi, President

Technofine Co., Ltd

Main Business Manufacture of pharmaceuticals
Location 342, Gensuke, Fujieda, Shizuoka, 426-8640, Japan
Contact Information TEL +81-54-636-7032
FAX +81-54-636-7055
Paid-in Capital ¥10 million (wholly owned by Mochida Pharmaceutical Plant)
Operations Commenced October 1, 2013
Representative Katsumi Takaada, President
Page top